Monitoring the Level of 14C-Labelled Selegiline Following Oral Administration. 2017

Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.

BACKGROUND Selegiline [(-)-deprenyl] is widely used for the treatment of Parkinson's disease in humans. OBJECTIVE Time-dependence of tissue distribution of selegiline following per os administration to rats. METHODS Oral administration of radiolabeled selegiline to rats resulted in a pattern of tissue distribution similar to that following intraperitoneal injection. Analyses were done using both reversed-phase HPLC and also by counting radioactivity in various body compartments of rats. RESULTS As a consequence of oral administration of 30 mg/kg of selegiline, its level in the stomach was extremely high (179.57 µg/g tissue through 54.67 µg/g at 15 min to 120 min), that is one magnitude higher than that in the serum level. High selegiline concentrations were also detected in the lacrimal glands (7.45 µg/g), kidneys (6.87 µg/g), livers (6.01 µg/g) and lungs (3.47 µg/g) after 30 minutes of application, which were higher than after intraperitoneal injections. CONCLUSIONS The relatively high tissue levels remained for 120 min monitoring. Selegiline levels in the brain (1.69 µg/g) and in the testes (1.88 µg/g) were also considerably higher than following intraperitoneal administration during the entire period of observation (15 to 120 min).

UI MeSH Term Description Entries

Related Publications

Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
January 1990, Journal of neural transmission. Supplementum,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
April 1970, Zeitschrift fur Tierphysiologie, Tierernahrung und Futtermittelkunde,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
January 1994, Drug metabolism and disposition: the biological fate of chemicals,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
January 1998, European journal of drug metabolism and pharmacokinetics,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
August 1982, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
March 1997, Arzneimittel-Forschung,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
April 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
August 2007, Analytical and bioanalytical chemistry,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
January 1986, European journal of drug metabolism and pharmacokinetics,
Huba Kalász, and Kornélia Tekes, and Erzsébet B Faigl, and Zita Pöstényi, and Eszter Berekméri, and Gellért Karvaly, and Ernest Adeghate
January 1990, Journal of analytical toxicology,
Copied contents to your clipboard!